NCT05834621撤回不适用
AMNIOmics: A Prenatal Rapid Genome Validation Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- Mayo Clinic
- 入组人数
- 90
- 主要终点
- Enrollment of study participants
研究概览
简要总结
The purpose of this study is to validate Whole Genome Sequencing (WGS) on amniotic fluid to reduce the time to diagnosis and enhance the care for the fetus/neonate.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Enrollment of study participants
时间窗: 5 years
To recruit up to 90 total participants including child and both parents
Validation of Rapid Whole Genome Sequencing technology on amniotic fluid samples
时间窗: 5 years
Collection of both amniotic fluid and blood samples to compare results of whole genome sequencing for a fetus with suspected genetic disease.
Collection of Biospecimens
时间窗: 5 years
Total number of biospecimens collected which may include both blood samples and amniotic fluid
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Whole Genome Sequencing in the Neonatal Intensive Care UnitGenetic Diseases, InbornNCT03721458Milton S. Hershey Medical Center3
Unknown
不适用
Perinatal Precision MedicineGenetic DiseasesGenetic SyndromeMendelian DisordersNCT03211039Rady Pediatric Genomics & Systems Medicine Institute213
已完成
不适用
Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy InfantsGenetic Predisposition to DiseaseHereditary DiseasesNCT05161169Brigham and Women's Hospital500
招募中
不适用
Genomic Sequencing in Anatomically Normal FetusesPregnant Individuals Requesting Standard MicroarrayNCT06211348University of California, San Francisco1,000
终止
不适用
Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGRHydrops FetalisFetal Growth RetardationNCT00143039Obstetrix Medical Group48